Cushman and Wakefield, the commercial real estate services firm, has acquired the entire team of Lemongrass Advisors, a real estate consultancy firm in Kolkata and eastern India, in a bid to augment its Kolkata operations, BL states.
With this acquisition, Abhijit Das- Founder and MD of Lemongrass Advisors, will lead the Kolkata operations as the new Office Director for the East.
The acquisition is unique in the sense that a corporate takeover was avoided in this instance to avert regulatory hassles and other necessary processes such as due diligence. Being a service company, talent is the real asset of a company, so C&W opted for talent acquisition.
Lemongrass will die natural death after three years when all receiveables of the company is obtained as per existing contracts.
C&W was planning to enter Bangladesh and Sri Lanka. While it will set up office in Dhaka by 2014, Sri Lanka may follow a year later.
Cushman & Wakefield is the largest privately held real estate services firm in the world. Founded in 1917, it has 195 offices in 55 countries around the globe, and 11,000+ talented professionals.
It commenced its India operations in 1997 and today has grown to over 700 employees across our offices based in New Delhi, Mumbai, Bangalore, Chennai, Hyderabad, Kolkatta and Pune. It offers a full range of real estate services combining local expertise and experience with technology and standards of service that are well established and consistent across all Cushman & Wakefield's offices worldwide.
Nalanda Capital backed IT solutions provider, Mindtree is looking for possible acquisition in US and Europe worth $30 - 50 Mn to strengthen its offerings in infrastructure management and package application solutions which would aid it deepen domain capabilities in its industry verticals -banking, financial services and insurance, retail, travel and hi-tech. The acquisition would be financed through cash and cash equivalent reserves which the firm holds which is to the tune of $200 Mn.
Telangana based Dr Reddy’s Laboratories is acquiring a select portfolio of Belgium based pharma company UCB in India for R800 Cr on a slump sale basis. The buy strengthens its presence in dermatology, respiratory and pediatrics segments.